Healthcare utilization and expenditures in patients with atrial fibrillation treated with catheter ablation

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 1, 2012, Pages 1-8

  Ladapo, Joseph A ^a,b   David, Guy ^c   Gunnarsson, Candace L ^d   Hao, Steven C ^e   White, Sarah A ^f   March, Jamie L ^f   Reynolds, Matthew R ^a,g  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d S2 Statistical Solutions Inc   (United States)

^e Sutter Pacific Medical Foundation   (United States)

^f Biosense Webster Belgium   (Belgium)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

atrial fibrillation; catheter ablation; health policy; healthcare expenditures; healthcare utilization; MarketScan; Medicare Supplemental Database

Indexed keywords

ADULT; AGED; ARTICLE; CATHETER ABLATION; COST CONTROL; COST OF ILLNESS; DRUG UTILIZATION; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEART ATRIUM FIBRILLATION; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; OUTPATIENT; PRIORITY JOURNAL;

AGED; AMBULATORY CARE; ATRIAL FIBRILLATION; CATHETER ABLATION; COST SAVINGS; COST-BENEFIT ANALYSIS; DRUG COSTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH RESOURCES; HOSPITAL COSTS; HOSPITALIZATION; HUMANS; INSURANCE, HEALTH; MALE; MEDICARE; MIDDLE AGED; OFFICE VISITS; REGRESSION ANALYSIS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84855988235     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2011.02130.x     Document Type: Article

References (32)

1. Lee WC, Lamas GA, Balu S, Spalding J, Wang Q, Pashos CL,: Direct treatment cost of atrial fibrillation in the elderly American population: A Medicare perspective. J Med Econ 2008; 11: 281-298.
2. Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P,: Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 2006; 9: 348-356. (Pubitemid 44337788)
3. Rohrbacker NJ, Kleinman NL, White SA, March JL, Reynolds MR,: The burden of atrial fibrillation and other cardiac arrhythmias in an employed population: Associated costs, absences, and objective productivity loss. J Occup Environ Med 2010; 52: 383-391.
4. Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, D'Agostino RB, Murabito JM, Kannel WB, Benjamin EJ,: Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: The Framingham Heart Study. Circulation 2003; 107: 2920-2925. (Pubitemid 36736633)
5. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ,: A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: The Framingham Heart Study. JAMA 2003; 290: 1049-1056. (Pubitemid 37430445)
6. Kim MH, Lin J, Hussein M, Kreilick C, Battleman D,: Cost of atrial fibrillation in United States managed care organizations. Adv Ther 2009; 26: 847-857.
7. Le Heuzey JY, Paziaud O, Piot O, Said MA, Copie X, Lavergne T, Guize L,: Cost of care distribution in atrial fibrillation patients: The COCAF study. Am Heart J 2004; 147: 121-126. (Pubitemid 38037407)
8. Ostrander LD Jr, Brandt RL, Kjelsberg MO, Epstein FH,: Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan. Circulation 1965; 31: 888-898.
9. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE,: Prevalence of diagnosed atrial fibrillation in adults. National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 2001; 285: 2370-2375. (Pubitemid 32424106)
10. Naccarelli GV, Varker H, Lin J, Schulman KL,: Increasing prevalence of atrial fibrillation and flutter in the United States. Am J Cardiol 2009; 104: 1534-1539.
11. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM,: Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 1994; 74: 236-241. (Pubitemid 24239044)
12. Aronow WS,: Management of the older person with atrial fibrillation. J Am Geriatr Soc 1999; 47: 740-748. (Pubitemid 29266646)
13. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, Williams CJ, Sledge I,: Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: Two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009; 2: 349-361.
14. Hunter RJ, Schilling RJ,: Long-term outcome after catheter ablation for atrial fibrillation: Safety, efficacy and impact on prognosis. Heart 2010; 96: 1259-1263.
15. Lubitz SA, Fischer A, Fuster V,: Catheter ablation for atrial fibrillation. BMJ 2008; 336: 819-826. (Pubitemid 351548225)
16. Rodgers M, McKenna C, Palmer S, Chambers D, Van Hout S, Golder S, Pepper C, Todd D, Woolacott N,: Curative catheter ablation in atrial fibrillation and typical atrial flutter: Systematic review and economic evaluation. Health Technol Assess 2008; 12:iii-iv, xi-xiii, 1-198.
17. Noheria A, Kumar A, Wylie JV Jr, Josephson ME,: Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: A systematic review. Arch Intern Med 2008; 168: 581-586. (Pubitemid 351468392)
18. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, Macle L, Daoud EG, Calkins H, Hall B, Reddy V, Augello G, Reynolds MR, Vinekar C, Liu CY, Berry SM, Berry DA, for the ThermoCool AF Trial Investigators: Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: A randomized controlled trial. JAMA 2010; 303: 333-340.
19. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A,: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 2005; 293: 2634-2640. (Pubitemid 40744248)
20. Forleo GB, Mantica M, De Luca L, Leo R, Santini L, Panigada S, De Sanctis V, Pappalardo A, Laurenzi F, Avella A, Casella M, Dello Russo A, Romeo F, Pelargonio G, Tondo C,: Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: Results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 2009; 20: 22-28.
21. Naccarelli GV, Johnston SS, Lin J, Patel PP, Schulman KL,: Cost burden of cardiovascular hospitalization and mortality in ATHENA-like patients with atrial fibrillation/atrial flutter in the United States. Clin Cardiol 2010; 33: 270-279.
22. Thomson Reuters MarketScan Research Data, 2009, accessed January 19, 2011.
23. Beinart SC, Kolm P, Veledar E, Zhang Z, Mahoney EM, Bouin O, Gabriel S, Jackson J, Chen R, Caro J, Steinhubl S, Topol E, Weintraub WS,: Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: From the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. J Am Coll Cardiol 2005; 46: 761-769. (Pubitemid 41224796)
24. Gibson TB, Mark TL, McGuigan KA, Axelsen K, Wang S,: The effects of prescription drug copayments on statin adherence. Am J Manag Care 2006; 12: 509-517. (Pubitemid 44412033)
25. Goldman HH, Frank RG, Burnam MA, Huskamp HA, Ridgely MS, Normand ST, Young AS, Barry CL, Azzone V, Busch AB, Azrin ST, Moran G, Lichtenstein C, Blasinsky M,: Behavioral health insurance parity for federal employees. N Engl J Med 2006; 354: 1378-1386.
26. Buck CJ,: 2011 ICD-9-CM for physicians, Vol. 1 and 2. Professional ed. St. Louis, MO: Elsevier Saunders, American Medical Association; 2011.
27. Stock JH, Watson MW,. Introduction to Econometrics. 2nd ed. Boston, MA: Pearson/Addison Wesley; 2007.
28. Marshall DA, Levy AR, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Greene HL, Wyse DG, Nichol G, O'Brien BJ, and the AFFIRM and CORE Investigators: Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 2004; 141: 653-661. (Pubitemid 39440011)
29. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, Gulletta S, Gugliotta F, Pappone A, Santinelli V, Tortoriello V, Sala S, Zangrillo A, Guiseppe C, Benussi S, Alfiero O,: Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Col Cardiol 2003; 42: 185-197. (Pubitemid 36851403)
30. Chan PS, Vijan S, Morady F, Oral H,: Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation. J Am Coll Cardiol 2006; 47: 2513-2520. (Pubitemid 43866357)
31. Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ,: Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2009; 2: 362-369.
32. Khaykin Y, Morillo CA, Skanes AC, McCracken A, Humphries K, Kerr CR,: Cost comparison of catheter ablation and medical therapy in atrial fibrillation. J Cardiovasc Electrophysiol 2007; 18: 907-913. (Pubitemid 47342400)